An underground economy for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.
Understanding Retatrutide
Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Voice Worries
However, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.
Some experts said the popularity for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate medicines, advertising, and consumer laws, risking penalties, legal action or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has taken down problematic material and banned related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Research also discovered groups with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of joining one group, a seller shared WhatsApp details, where the majority of purchases take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, health issues or previous experience.
Product Details and Pricing
Within these groups, posts display black plastic parcels with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service said it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has already seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially serious medical dangers”.
